6 January 2025 - Taxpayers would fund popular weight loss drugs for people with severe obesity under a proposal from American pharmaceutical giant Eli Lilly to have Mounjaro listed on the PBS.

The move, which is being seen as a test case for Canberra’s willingness to subsidise the new-class of blockbuster medicines used by millions of people to lose weight, follows a decision to make Mounjaro available on Britain’s public health care system to some patients.

Read Australian Financial Review article